{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:07:15Z","timestamp":1779138435705,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jns.2025.123552","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:09:21Z","timestamp":1748545761000},"page":"123552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of brain volume on coronavirus disease of 2019 severity and subsequent cognitive decline in patients with multiple sclerosis"],"prefix":"10.1016","volume":"475","author":[{"given":"Jens","family":"Devogelaere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Van Remoortel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia Della","family":"Faille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie B.","family":"D'hooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Van Schependom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Stastna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Uher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Nagels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"D'Haeseleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2025.123552_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.jns.2025.123552_bb0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123552_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamaneurol.2021.0688","article-title":"Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis","volume":"78","author":"Salter","year":"2021","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.jns.2025.123552_bb0020","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1111\/ene.14690","article-title":"COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response","volume":"28","author":"Zabalza","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2025.123552_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11882-023-01102-0","article-title":"Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches","volume":"23","author":"Vasileiou","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"issue":"11","key":"10.1016\/j.jns.2025.123552_bb0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123552_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103144","article-title":"Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability","volume":"54","author":"Cohen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.jns.2025.123552_bb0040","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028969","article-title":"Magnetic resonance imaging in multiple sclerosis","volume":"8","author":"Hemond","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.jns.2025.123552_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nic.2017.01.002","article-title":"Brain atrophy in multiple sclerosis: clinical relevance and technical aspects","volume":"27","author":"Sastre-Garriga","year":"2017","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jns.2025.123552_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13317-019-0117-5","article-title":"Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options","volume":"10","author":"Andravizou","year":"2019","journal-title":"Auto Immun. Highlights"},{"issue":"3","key":"10.1016\/j.jns.2025.123552_bb0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5114\/fn.2021.109495","article-title":"Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer\u2019s disease brain","volume":"59","author":"Zhao","year":"2021","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.jns.2025.123552_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104754","article-title":"A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity","volume":"136","author":"Safaei","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"9","key":"10.1016\/j.jns.2025.123552_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.518","article-title":"Reliable measurements of brain atrophy in individual patients with multiple sclerosis","volume":"6","author":"Smeets","year":"2016","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.jns.2025.123552_bb0070","first-page":"202","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jns.2025.123552_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1045101","article-title":"Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: lessons learnt a year in","volume":"13","author":"Pugliatti","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jns.2025.123552_bb0080","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/jnnp-2022-329123","article-title":"Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis","volume":"93","author":"Etemadifar","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2025.123552_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ensci.2017.05.002","article-title":"Definition, prevalence and predictive factors of benign multiple sclerosis","volume":"7","author":"Reynders","year":"2017","journal-title":"eNeurologicalSci"},{"issue":"6","key":"10.1016\/j.jns.2025.123552_bb0090","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hbm.23168","article-title":"Postmortem validation of MRI cortical volume measurements in MS","volume":"37","author":"Popescu","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"7","key":"10.1016\/j.jns.2025.123552_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2679","article-title":"Grey matter atrophy in patients with benign multiple sclerosis","volume":"12","author":"Niiranen","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.jns.2025.123552_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102485","article-title":"Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration","volume":"46","author":"Ellenberger","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.123552_bb0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(17)30076-5","article-title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study","volume":"16","author":"Wijnands","year":"2017","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.jns.2025.123552_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-021-00519-3","article-title":"The multiple sclerosis prodrome","volume":"17","author":"Makhani","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2025.123552_bb0115","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1111\/ene.14879","article-title":"Impact of the COVID-19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy","volume":"28","author":"Colais","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2025.123552_bb0120","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1111\/ene.14990","article-title":"Risk and outcomes of COVID-19 in patients with multiple sclerosis","volume":"28","author":"Moreno-Torres","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123552_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001105","article-title":"COVID-19 severity in multiple sclerosis: putting data into context","volume":"9","author":"Sormani","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.jns.2025.123552_bb0130","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jamaneurol.2020.2581","article-title":"Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis","volume":"77","author":"Louapre","year":"2020","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123552_bb0135","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.26028","article-title":"Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis","volume":"89","author":"Sormani","year":"2021","journal-title":"Ann. Neurol."},{"issue":"19","key":"10.1016\/j.jns.2025.123552_bb0140","doi-asserted-by":"crossref","first-page":"e1870","DOI":"10.1212\/WNL.0000000000012753","article-title":"Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis","volume":"97","author":"Simpson-Yap","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2025.123552_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001024","article-title":"SARS-CoV-2 infection in multiple sclerosis: results of the Spanish neurology society registry","volume":"8","author":"Arrambide","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.jns.2025.123552_bb0150","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200089","article-title":"Occurrence and severity of coronavirus disease 2019 are associated with clinical disability worsening in patients with multiple sclerosis","volume":"10","author":"Peeters","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2025.123552_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/ene.15488","article-title":"Impact of vaccination on COVID-19 outcome in multiple sclerosis","author":"Bsteh","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2025.123552_bb0160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/13524585221134216","article-title":"T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy","volume":"29","author":"Reder","year":"2023","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"7","key":"10.1016\/j.jns.2025.123552_bb0165","article-title":"Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment","volume":"31","author":"De Troyer","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123552_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp-2022-330100","article-title":"SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis","volume":"94","author":"van Kempen","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.jns.2025.123552_bb0175","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/13524585231185246","article-title":"Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: an observational study by the New York COVID-19 neuro-immunology consortium (NYCNIC-2)","volume":"29","author":"Klineova","year":"2023","journal-title":"Mult. Scler."},{"issue":"13","key":"10.1016\/j.jns.2025.123552_bb0180","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1177\/13524585221102918","article-title":"Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies","volume":"28","author":"Schiavetti","year":"2022","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.jns.2025.123552_bb0185","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/13524585231167515","article-title":"Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs","volume":"29","author":"Capuano","year":"2023","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jns.2025.123552_bb0190","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/ene.15477","article-title":"Long-term outcome after COVID-19 infection in multiple sclerosis: A nation-wide multicenter matched-control study","volume":"29","author":"Bsteh","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123552_bb0195","first-page":"342","article-title":"COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study","volume":"95","author":"Montini","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2025.123552_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.582345","article-title":"How does SARS-CoV-2 affect the central nervous system? A working hypothesis","volume":"11","author":"Panariello","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2025.123552_bb0205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12028-020-01049-4","article-title":"Neurological involvement in COVID-19 and potential mechanisms: a review","volume":"34","author":"Aghagoli","year":"2021","journal-title":"Neurocrit. Care."},{"issue":"10","key":"10.1016\/j.jns.2025.123552_bb0210","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/diagnostics13101716","article-title":"Brain volume changes after COVID-19 compared to healthy controls by artificial intelligence-based MRI Volumetry","volume":"13","author":"Bendella","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jns.2025.123552_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2024.103631","article-title":"Brain microstructure and connectivity in COVID-19 patients with olfactory or cognitive impairment","volume":"43","author":"Arrigoni","year":"2024","journal-title":"NeuroImage Clin."},{"issue":"3","key":"10.1016\/j.jns.2025.123552_bb0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WCO.0000000000001264","article-title":"Current opinion: racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health","volume":"37","author":"Robers","year":"2024","journal-title":"Curr. Opin. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T09:39:25Z","timestamp":1754473165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S0022510X25001698"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123552","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of brain volume on coronavirus disease of 2019 severity and subsequent cognitive decline in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123552"}}